Manuel Kadre - 13 May 2025 Form 4 Insider Report for NeueHealth, Inc. (NEUE)

Role
Director
Signature
/s/ Eric Halverson for Manuel Kadre, Attorney-in-Fact
Issuer symbol
NEUE
Transactions as of
13 May 2025
Net transactions value
$0
Form type
4
Filing time
15 May 2025, 18:34:52 UTC
Previous filing
17 Apr 2025
Next filing
27 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Kadre Manuel Director C/O NEUEHEALTH, INC., 8000 NORMAN CENTER DRIVE, SUITE 900, MINNEAPOLIS /s/ Eric Halverson for Manuel Kadre, Attorney-in-Fact 15 May 2025 0001396538

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEUE Common Stock Options Exercise $0 +10,500 +54% $0.000000 29,820 13 May 2025 Direct
holding NEUE Common Stock 3,686 13 May 2025 See note 1. F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NEUE Restricted Stock Units Options Exercise $0 -10,500 -100% $0.000000 0 13 May 2025 Common Stock 10,500 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects securities held by Kadre Family Partnership, L.P., a family limited partnership, of which the Reporting Person is the general partner.
F2 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F3 All of these restricted stock units vested on May 13, 2025, one year from the grant date.